International Patent: USE OF RECOMBINANT APOLIPOPROTEIN J IN PREPARATION OF DRUG FOR TREATING KERATINIZATION AND SQUAMOUS METAPLASIA

GENEVA, Oct. 15 -- XIAMEN HONG-GUAN BIOTECH CO., LTD. filed a patent application (CN2026/085543) for “USE OF RECOMBINANT APOLIPOPROTEIN J IN PREPARATION OF DRUG FOR TREATING KERATINIZATION AND SQUAMOUS METAPLASIA”. With publication no. WO/2026/214405, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/17

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....